Comparison of OS for reported factors in large MF cohort studies
| Characteristics | Long-term outcome of 525 patients (Kim and colleagues; 9) | Validation of ISCL/EORTC. 1,502 patients (Agar and colleagues; 10) | MDACC study of 1,263 MF/SS patients |
|---|---|---|---|
| Time duration | 1958–1999 | 1980–2009 | 1982–2009 |
| Mycosis fungoides (n) | 490 | 1,398 | 1,062 |
| Sézary syndrome (n) | 35 | 104 | 186 |
| Male (n) | 330 | 933 | 663 |
| Median OS | 10 y | 13.4 y | 20.7 y |
| Female (n) | 195 | 569 | 585 |
| Median OS | 13.5 y | 24.1 y | 32.0 y |
| T classification | |||
| T1 (n) | 159 | 443 | 521 |
| Median OS | Not reached | 35.5 years | Not reached |
| T2 (n) | 192 | 628 | 395 |
| Median OS | 12.1 y | 21.5 y | 26.26 y |
| T3 (n) | 96 | 182 | 136 |
| Median OS | 3.3 y | 4.1 y | 5.96 y |
| T4 (n) | 78 | 234 | 188 |
| Median OS | 4 y | 3.9 y | 5.00 y |
| Folliculotropic MF (n) | 189 | 44 | |
| Median OS | 12.2 y | Not reached | |
| Poikiloderma | 168 | 63 | |
| Median OS | 20.1 y | Not reached | |
| Hypopigmented MF (n) | 51 | 54 | |
| Median OS | Not reached | 32.04 y | |
| Lyp and MF (n) | 74 | 45 | |
| Median OS | Not reached | Not reached | |
| B0 (n) | 490 | 1327 | 1042 |
| Median OS | 12.3 y | 24.5 y | 29.28 y |
| B1 (n) | 35 | 71 | 13 |
| Median OS | 3 y | 3.2 y | Not reached |
| B2 (n) | 0 | 104 | 186 |
| Median OS | 3.1 y | 4.64 y | |
| N0 (n) | 345 | 1,220 | 1,112 |
| Median OS | 17.4 y | 22.8 y | 26.26 y |
| N1 (n) | 147 | 87 | 55 |
| Median OS | 6.5 y | 5.2 y | 16.91 y |
| N2 (n) | 8 | 28 | |
| Median OS | 1.1 y | 5.43 y | |
| N3 (n) | 33 | 40 | 18 |
| Median OS | 1.7 y | 2 y | 6.13 y |
| N4 (n) | 33 | ||
| Median OS | 2.85 y | ||
| Extracutaneous (n) | 77 | 13 | 70 |
| Median OS | 1.1 y | 1.4 y | 4.42 y |